- Report
- April 2023
- 80 Pages
Brazil
From €1370EUR$1,500USD£1,172GBP
- Report
- April 2023
- 80 Pages
Argentina
From €1370EUR$1,500USD£1,172GBP
- Report
- April 2023
- 180 Pages
Global
From €2283EUR$2,500USD£1,953GBP
- Report
- April 2023
- 100 Pages
Africa
From €1827EUR$2,000USD£1,562GBP
- Report
- April 2024
- 132 Pages
Global
From €868EUR$950USD£742GBP
Pertussis, also known as whooping cough, is a highly contagious respiratory infection caused by the bacterium Bordetella pertussis. It is a major cause of morbidity and mortality in children, particularly in developing countries. In pulmonary medicine, pertussis is treated with antibiotics, such as macrolides, and supportive care. Vaccination is the most effective way to prevent pertussis, and is recommended for all children and adults.
The pertussis market is a subset of the global pulmonary medicine market, which is estimated to reach $50 billion by 2027. The pertussis market is driven by the increasing prevalence of the disease, the rising demand for vaccines, and the growing awareness of the importance of vaccination.
Some companies in the pertussis market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Johnson & Johnson. Show Less Read more